Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HDC Laboratory is a Japanese biotechnology company focused on the research and development of novel therapeutic agents targeting the histidine decarboxylase (HDC) enzyme. The company specializes in the discovery of HDC inhibitors to treat histamine-related disorders, including allergic diseases and gastrointestinal conditions. By leveraging its expertise in enzyme inhibition, HDC Laboratory aims to develop more effective treatments for indications such as allergic rhinitis and atopic dermatitis. In addition to its pharmaceutical pipeline, the company explores applications of its research in health foods and specialized cosmetics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HDC laboratory.